Home
About BEB
Curriculum
Admission
CNC Research
BEB in the Media
 
 
PRINCIPLES AND PRACTICE IN DRUG DEVELOPMENT - ELECTIVE COURSE - MIT-PORTUGAL PROGRAM 2017/2018
 
May 21 - 30
Coordinator: João Nuno Moreira: jmoreira@ff.uc.pt
PRINCIPLES AND PRACTICE IN DRUG DEVELOPMENT I ELECTIVE COURSE
with MIT-PT Bioengineering Doctoral Program

Center for Neuroscience and Cell Biology (CNC) I University of Coimbra
May 21 - May 30, 2018


João Nuno Moreira, Luís Pereira de Almeida, Sérgio Simões, Stan Finkelstein


Venue: CNC auditorium (Polo I); former Faculty of Medicine, 2nd floor.
Access to Park P4 for invited speakers: on your left side at Rua São João, 3000-370 Coimbra
(Coordinates from Google Maps: 40.208235, -8.424829)

NOTE: last minute changes to the program might take place; please take a look at the program (available in google docs) before each class.


May 21 - Monday
10.00 h - Introduction to the course
João Nuno Moreira I PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Luís Pereira de Almeida I PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Sérgio Simões I PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Stan N. Finkelstein I MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)

11.00 h - The Pharmaceutical Industry and the Drug Development Process
Stan N. Finkelstein I MD, PhD (Senior Research Scientist in the MIT Engineering Systems Division and Associate Professor of Medicine, Harvard Medical School)

14.00 h - Basic Science I – Discovery Innovation and Emerging Technologies; Basic Business
Anthony J. Sinskey I PhD (Professor of Biology at MIT)

16.00 h - Building predictive models for oncology drug discovery
Darrin Stuart I PhD (Director, Cell Biology/Small Molecule Drug Discovery, Novartis Institutes for Biomedical Research, Cambridge, USA)


May 22 - Tuesday
09.30 h - FDA Process, Off-Label Prescribing, Insurance Coverage
Stan N. Finkelstein I MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)

16:00 h - Re-Engineering the Drug Business
Robert Mulroy I Chairman and CEO of Partners Oncology, Inc


May 23 - Wednesday
10.00 h - Modeling chemistry and biology in drug discovery
Nuno Palma I PhD (BIAL, Indústria Farmacêutica, Portugal)

11.30 h - Development of small molecule inhibitors for treatment of CNS disorders
Laszlo Kiss I PhD (BIAL, Indústria Farmacêutica, Portugal)


14.30 h - Pharmacology and toxicology of new chemical entities
Lyndon C. Wright I PhD (BIAL, Indústria Farmacêutica, Portugal)

16:00 h - Clinical development of new chemical entities
Ana Santos I BSc (BIAL, Indústria Farmacêutica, Portugal)


May 24 - Thursday
9.30 h - Visit to Biocant Park – Innovation Center in Biotechnology
(by bus; meeting point: in front of the Department of Mathematics - Largo D. Dinis)

14.00 h - Nanotechnology for drug targeting and the impact on drug development
João Nuno Moreira I PhD
Vera Moura I PhD (CEO of TREAT U, SA and CNC)
Nuno Fonseca  I PhD (TREAT U, SA, and CNC)

16.30 h - Translational insights in clinical trials: application of molecular and cellular data to inform patient stratification and analyze efficacy
Daniel Lopes de Menezes I PharmD, MSc, PhD (Translational Development group at Celgene Corporation)


May 25 - Friday
9.00 h - Bluepharma Pharmaceutical Industry SA: from development of generics to innovative research and site visit
Sérgio Simões I PhD
(Bluepharma address: Rua Bayer, 3045-016 São Martinho do Bispo - Coimbra; suggested transportation: bus no. 6, in front of the University Hospital or at Praça da República, http://www.smtuc.pt/avisos/index.php?id=490)

14.30 h - Photodynamic therapy in oncology
Cláudia Silva I PharmD, PhD (Head of Research and Innovation at Blupharma; COO/deputy CEO@Luzitin)


May 28 – Monday
10.00 h - Some issues in drug development: discussion of case studies
Miguel Prazeres I PhD (Instituto Superior Técnico, Technical University of Lisbon)

14.30 h - The Role of Quality by Design in the Pharmaceutical Industry
Pedro Valente I PhD (Senior Scientist, R&D Drug.Product Development, Hovione, Portugal)

16.30 h - Nanotechnology for drug and gene targeting and the impact on drug development (cont.)
Luís Pereira de Almeida I PhD (CNC)
Rui Nobre I PhD (CNC)
Liliana Mendonça I PhD (CNC)
Ana Rita Álvaro I PhD (CNC)
Carlos Matos I PhD (CNC)


May 29 - Tuesday
10.30 h - From research to health care: regulatory affairs and regulatory science helping to shape an integrated healthcare system
Rogério Gaspar I PhD (iMed.UL and Faculty of Pharmacy, University of Lisbon)

14:30 - Translational research and the role of non clinical studies
Beatriz Silva Lima I PhD (Faculty of Pharmacy, University of Lisbon and President of the Scientific Council of the Innovative Medicines Initiative, IMI2)


May 30 - Wednesday
9 h - Students presentations



back
 
© 2018 BEB - Doctoral Programme in Experimental Biology and Biomedicine powered by ponto.C